Evidence map›Paper›PMID 32672937›Full record

ArticleACS applied materials & interfaces2020

Antibody-Enabled Antimicrobial Nanocapsules for Selective Elimination of

Kristina Ivanova, Aleksandra Ivanova, Eva Ramon, Javier Hoyo, Susana Sanchez-Gomez, Tzanko Tzanov

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Antibiotic Resistance ofPharmaceuticals (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kristina IvanovaGrup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering, Universitat Politècnica de Catalunya, Rambla Sant Nebridi 22, Terrasa, Barcelona 08222, Spain.
Aleksandra IvanovaGrup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering, Universitat Politècnica de Catalunya, Rambla Sant Nebridi 22, Terrasa, Barcelona 08222, Spain.
Eva RamonGrup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering, Universitat Politècnica de Catalunya, Rambla Sant Nebridi 22, Terrasa, Barcelona 08222, Spain.
Javier HoyoGrup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering, Universitat Politècnica de Catalunya, Rambla Sant Nebridi 22, Terrasa, Barcelona 08222, Spain.ORCID http://orcid.org/0000-0002-9927-2465
Susana Sanchez-GomezBionanoplus S.L., Pol. Mocholi, Plaza Cein No. 5, nave B14, Noain, Navarre 31110, Spain.
Tzanko TzanovGrup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering, Universitat Politècnica de Catalunya, Rambla Sant Nebridi 22, Terrasa, Barcelona 08222, Spain.ORCID http://orcid.org/0000-0002-8568-1110
Universitat Politècnica de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted bactericide nanosystems hold significant promise to improve the efficacy of existing antimicrobials for treatment of severe bacterial infections, minimizing the side effects and lowering the risk of the development of antibiotic resistance. In this work, we developed antibody-functionalized nanocapsules (NCs) containing antibacterial essential oil (EO) for selective and effective eradication of

Indexed as

AntibodiesAnti-Infective AgentsDrug Resistance, MicrobialFibroblastsHumansMicrobial Sensitivity TestsMolecular Targeted TherapyNanocapsulesOils, VolatilePseudomonas aeruginosaStaphylococcal InfectionsStaphylococcal Protein AStaphylococcus aureusAntibodiesAnti-Infective AgentsNanocapsulesOils, VolatileStaphylococcal Protein Aantibiotic resistanceessential oilselective antibacterial activityStaphylococcus aureustargeting antibodyzein nanocapsules

Identifiers

PMID32672937
PMCPMC7497629
OpenAlexW3043268761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.